Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.048 0.2
mRNA CHIR-99021 GDSC1000 pan-cancer AAC 0.044 0.2
mRNA linifanib CTRPv2 pan-cancer AAC -0.05 0.2
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.047 0.2
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.046 0.2
mRNA OSI-930 GDSC1000 pan-cancer AAC -0.047 0.2
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA Sunitinib FIMM pan-cancer AAC -0.23 0.2
mRNA FR-180204 GDSC1000 pan-cancer AAC -0.046 0.2
Download CSV